Upgrade to SI Premium - Free Trial

Genmab A/S (GMAB) PT Lowered to $38 at H.C. Wainwright

April 30, 2026 6:50 AM
(Updated - April 30, 2026 6:52 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Genmab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change